Molecular Imaging, a contract research organization (CRO) providing multi-modality preclinical in vivo imaging services to pharmaceutical and biotechnology companies, has entered into a licensing agreement with Dana-Farber Cancer Institute in Boston to access a number of luciferase-enabled cancer cell lines developed at Dana-Farber.
Medical terminology since the age of healthcare reform has shifted from a vocabulary such as vasospasms and angina to an entirely new language that turns patients into “customers” or “consumers” and doctors into "providers," according to a perspective published Oct. 13 in the New England Journal of Medicine.
The Health Care Cost Institute (HCCI), a health research initiative led by payors Aetna, Humana, Kaiser Permanente and UnitedHealthcare, was launched to allow researchers and policymakers access to a collection of health plan and government payor data. The HCCI said this initiative will offer new insights into healthcare costs, utilization and intensity, as well as inform the public policy process and assist in developing new solutions to long-term problems confronting the healthcare system.
Written by Lisa Fratt
Microscopic gold particles could multiply the effectiveness of standard cancer radiation therapy by acting as tiny missiles that destroy blood vessels feeding cancerous tumors. Early research about this method, which could shorten cancer treatment and make it more effective, is being presented at the 2011 Joint Meeting of the American Association of Physicists in Medicine (AAPM) and Canadian Organization of Medical Physicists (COMP).
Women with mammographically dense breasts not only face a higher risk of breast cancer, but their tumors also are more likely to have more aggressive characteristics than women with less dense breasts, according to a study published online July 27 in the Journal of the National Cancer Institute.
Sunday, June 5 | 8:30 AM - 10:15 AM
Ballroom A
Cardiac CT offers physicians strong predictions of major adverse cardiac events (MACE) in ED patients presenting with chest pain, supplementing clinical risk scores and offering a two-year MACE-free warranty period in the absence of coronary artery disease (CAD), according to the two-year outcomes of the ROMICAT study published in the May issue of the Journal of the American College of Cardiology.
Siemens Healthcare has appointed neurologist Gregory Sorensen, MD, as CEO of Siemens Healthcare in the U.S., effective June 1. Sorensen succeeds Randy Hill, who has served as interim CEO. Sorensen also will oversee the Canadian activities of Siemens Healthcare.
Written by Clint vanSonnenberg
Radiation was brought to the fore within pediatric nuclear medicine following the release of a 2008 study which revealed a chaotic disarray of administered doses within North America’s premier pediatric institutions, including radiopharmaceutical doses varying by factors of as much as 10 in most children and by up to 20 in infants (J Nucl Med 2008; 49:1024–1027).
Researchers suggested links between cardiac CT triage and three key benefits—fewer invasive catheterizations, improved survival and reduced costs—in a simulation model of the clinical and economic outcomes of low-risk patients with acute chest pain in the emergency department, according to a study published in the April issue of the American Journal of Roentgenology.
Written by Clint vanSonnenberg
Time-of-flight PET may improve detection of lesions in cancer patients, demonstrating enhanced visibility of artificially fused lesions in the lungs and liver across patients of varying weights, contrasts and scanning times, according to a study published in the March issue of the Journal of Nuclear Medicine.
|
|
|
|
RSS 
